Delivery Order SPE2DR25D3005-SPE2DR26FP8EP
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $4,483.25 to AmerisourceBergen Drug Corp for the supply of Arimidex 1 mg tablets (30-count package) on November 3, 2025, with completion scheduled for November 4, 2025. This firm fixed-price delivery order represents a non-set-aside award and is performed at AmerisourceBergen's Conshohocken, Pennsylvania facility. The award reflects AmerisourceBergen's role as a critical pharmaceutical distributor within the federal medical supply...
- The Defense Logistics Agency awarded a delivery order valued at $4,980.75 to AmerisourceBergen Drug Corp for Arimidex 1 mg tablets (30-count packages) under a firm fixed-price contract. This non-set-aside award was issued on December 22, 2025, with completion expected by December 23, 2025. The product will be delivered to AmerisourceBergen's corporate headquarters location in Conshohocken, Pennsylvania. This delivery order is a child contract under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $4,389.99 on December 8, 2025, for the supply of Arimidex 1 mg tablets in quantities of 30 units. This competitively awarded, firm fixed-price contract is scheduled for completion by December 9, 2025, with performance taking place at the vendor's corporate office location in Conshohocken, Pennsylvania. The delivery order carries no set-aside designation, reflecting the contractor's ability to compete in...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $4,215.65 to AmerisourceBergen Drug Corp on November 14, 2025, for the supply of Arimidex 1 mg tablets (30 count). The award is non-competitive and issued under a firm fixed-price delivery order contract type, with an ultimate completion date of November 17, 2025. The place of performance is listed as AmerisourceBergen's corporate office in Conshohocken, Pennsylvania, where the company maintains its headquarters as a major...
- The Defense Logistics Agency awarded a delivery order valued at $6,591.89 to AmerisourceBergen Drug Corp for the supply of Arimidex 1 mg tablets (30-count units) on November 4, 2025, with completion scheduled for November 5, 2025. This is a firm fixed price delivery order with no set-aside designation, indicating the award was made through open competition. The product will be delivered to AmerisourceBergen's place of performance in Conshohocken, Pennsylvania, where the company maintains its...
- The Defense Logistics Agency awarded a delivery order valued at $10,006.96 to AmerisourceBergen Drug Corp for the supply of Arimidex 1 mg tablets (30 count). This firm fixed-price delivery order, awarded on October 24, 2025, with an ultimate completion date of October 27, 2025, represents a direct pharmaceutical procurement supporting federal medical supply requirements. The award was competitively awarded with no set-aside designation and is being performed at AmerisourceBergen's corporate...
- The Defense Logistics Agency awarded a $12,971.08 firm fixed price delivery order to AmerisourceBergen Drug Corp for the supply of Arimidex 1 mg tablets (30-count) with an ultimate completion date of December 24, 2025. This non-set-aside contract was competitively awarded and represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical. The pharmaceutical distributor, headquartered in Conshohocken, Pennsylvania, will perform this...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Arimidex (anastrozole) 1 mg tablets in a 30-count package, with a contract ceiling value of $5,731.74. This competitively awarded, non-set-aside delivery order has a firm fixed price structure and an ultimate completion date of December 24, 2025. The award was executed on December 23, 2025, with performance taking place at AmerisourceBergen's corporate office location in Conshohocken,...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $7,848.34 to AmerisourceBergen Drug Corp for the supply of Arimidex 1 mg tablets (30-count units) under a firm fixed price contract. The award was made on December 17, 2025, with an ultimate completion date of December 18, 2025, and represents a non-set-aside, competitively awarded procurement. The pharmaceutical products will be delivered to Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Arimidex 1 mg tablets (30-count units) with a ceiling value of $11,463.48. This competitively awarded, firm fixed-price delivery order, issued on December 23, 2025, with an ultimate completion date of December 24, 2025, represents a single transaction under AmerisourceBergen's larger indefinite delivery contract with DLA. The place of performance is the vendor's corporate office in...
- SPE2DR25D3005Indefinite Delivery Contract
- SPE2DR25D3005-SPE2DR26FP8EPDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $4,973.52 to AmerisourceBergen Drug Corp for the supply of Arimidex (anastrozole) 1 mg tablets in a 30-count package. This non-set-aside contract was awarded on December 23, 2025, with an ultimate completion date of December 24, 2025, and is structured as a firm fixed price delivery order. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This award represents a routine pharmaceutical supply transaction typical of the company's extensive portfolio of federal medical procurement activities. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The parent contract serves as a comprehensive global pharmaceutical support vehicle enabling the company to supply a wide range of pharmaceutical products and medical supplies to support military healthcare programs worldwide. AmerisourceBergen's consistent success in competitively awarded contracts with the DLA demonstrates its capability to fulfill federal medical supply requirements across multiple therapeutic domains, including specialty medications, brand-name and generic drugs, and related medical commodities serving the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $5.0k | 12/22/25 |